Navnoor Bawa Research

Navnoor Bawa Research

Fund Teardowns

Steve Cohen's Point72 Turion Fund, Measured Against His Flagship

Morgan Stanley's richest clients can now buy Cohen's AI fund. UBS's books show whether they get the hedged Point72 or the AI trade.

Navnoor Bawa's avatar
Navnoor Bawa
Oct 20, 2026
∙ Paid
The Point72 Asset Management logo, its dot mark and wordmark in white on a dark ground

On 15 July 2026, Michael Stanton signed the papers for a Morgan Stanley feeder into Turion, Steve Cohen’s AI fund. He signed for its general partner, an affiliate of iCapital, which became Morgan Stanley’s feeder fund service provider in 2019; HedgePremier is the name on those feeders for wealth clients. No client had bought on filing day.

Morgan Stanley can now offer its richest clients Point72’s AI fund, which fell 11.4% in July while Point72’s flagship fell 3.3%, Hedgeweek reported, citing Bloomberg. The Point72 those clients know is the flagship, the diversified platform the firm’s own Form ADV brochure calls its Multi-Strat Funds. The same brochure files Turion apart, among funds that “pursue a single investment strategy”.

So which fund does a buyer get? The same-ledger test reads the books of one UBS fund that owns both, turning its quarterly marks on each into returns. Its marks for the quarter to December cover October. In the week to 15 October, Goldman Sachs’s prime brokerage data showed hedge funds cutting technology at the fastest proportional pace since its records began in 2016, Hedgeweek reported. A feeder client’s money rides on which fund those marks describe.

I read Point72’s registration, every Form D filed for Turion’s feeders and the quarterly filings of two UBS funds that own Turion.

Six chapters make the case:

  • Cohen built Turion to be different: one theme, few names, and a gain of about 30% by mid-November 2025.

  • Outside money, sold by outsiders: two outside distributors filed this summer to offer Turion.

  • Morgan Stanley’s shelf added the theme: a buyer pays two layers of fees, into a fund with a 25% gate.

  • One UBS ledger marks both funds: two kinds of UBS filing turn into a return series for each fund.

  • Turion’s slope against the flagship’s: settles how far each fund moves with the Nasdaq-100 and with chip stocks.

  • What a Turion buyer holds: settles who sits beside him, what he pays for, and the dated test.

Subscribe to get each piece by email, with its sources and the test that would prove it wrong.

Cohen built Turion to be different

The brochure gives Turion a narrower job than the flagship’s. Point72 launched it in October 2024, when its onshore feeder made its first sale. The main funds pursue “long/short equity, systematic and global macro investment strategies”. Turion’s are “focused on investment in technology and technology-enabled businesses believed to be impacted by artificial intelligence”, their holdings “expected to be concentrated in a limited number of financial instruments”. So the flagship spreads risk across many books and styles, and Turion puts it into one theme and a short list of names.

Turion’s chain of control runs to Cohen: Point72 Turion GP, LLC, its general partner, runs the funds, and Turion’s onshore and offshore partnerships’ Form Ds name Steven A. Cohen as “Sole beneficial owner of the Managing Member of the Issuer’s General Partner”. Eric Sanchez, Turion’s portfolio manager according to Hedgeweek, runs the book. The brochure’s Turion section gives the fund’s premise: “Point72 believes outsized returns come from variant investment opinions resulting from deep fundamental research in sectors experiencing rapid change.”

Cohen said what he thought of the sector four months after Turion’s first sale. “We’re in the early stages of something transformational,” he told the iConnections conference in Miami on 28 January 2025, Hedgeweek reported. “Great companies are going to be expensive,” he said. A fund built around the second sentence needs room to stay long through a rally. Hedgeweek says Turion has that room: “a wider mandate than the hedge fund manager’s main fund, giving it the flexibility to hold longer-biased positions”. Hedgeweek reported on 12 November 2025 that Turion had made about 30% on the year, including about 9% in October.

The printed view of Turion is that it is a long short book. Reuters, on 16 January 2025, called it “the hedge fund that picks winners and losers in the AI supply chain”. the annual report of A&Q Long/Short, the UBS fund that owns both, says that at the end of 2025 “the Fund was invested in Investment Funds that employed Equity Hedged strategy”, Turion and the flagship among them. Both can be true while Turion moves with the market, since a book can run shorts and still be mostly long.

July put Turion in its league. The Nasdaq-100 fell 6.6% that month and the chip index, the PHLX Semiconductor index, 20.6%; Turion fell 1.7 times as far as the first and about half as far as the second.

Its loss sat beside Altimeter’s 11% and the 21.7% lost by Whale Rock’s flagship on Hedgeweek’s list of the month’s biggest losers. The platforms barely moved: Millennium lost 2.1% and Balyasny 1.5%. Point72’s flagship fell about half as far as the Nasdaq-100. In July the fund built on one theme lost with that list.

Outside money, sold by outsiders

Turion is small inside Point72, and most of the money in it comes from outside. Alex Morrell of Business Insider reported that “Point72 hit $50 billion in assets in April” and that Turion had “nearly $4 billion”, so about 8% of the firm’s capital sits in the AI fund.1

Point72’s registration shows who holds it. At the end of 2025, Turion’s master had 121 beneficial owners, and investors outside the US held 63% of it, against 49% of the flagship’s main fund, Point72 Associates, LLC.

The feeders split the inside money unevenly. The offshore partnership, Point72 Turion Offshore, L.P., had $2.17bn of gross assets and 48 owners, and 79% of it was owned from outside the US. Point72 and its related persons, among them its affiliates, Cohen and its employees, owned none of it. The onshore feeder, Point72 Turion Onshore, L.P., was the US door: 11% of it was owned from abroad, and 42% of its $610m belonged to Point72 and its people. So the firm’s own money sits on the US side.

The feeders’ filings show what came in after Cohen made his case. Each Form D reports cumulative sales since the first sale, gross of redemptions, and the amendments filed in September 2025 and September 2026 sit a year apart.

Over that year the onshore feeder sold another $160m to 36 more investors. The offshore partnership sold another $144m to 11 more. Together Point72’s three Turion feeders, the third an offshore company, report $1.29bn of Regulation D sales to 177 investors since 2024, about $7m a head.

Two new doors opened this summer, and neither is Point72’s. ShoreBridge Point72 Turion filed on 25 June 2026, to be sold by ShoreBridge Capital Securities, of Summit, New Jersey, in 13 states. HedgePremier/Point72 Turion followed on 15 July, and neither had made a sale when it filed.

So the AI fund is small beside the firm, owned more from abroad than the flagship, and now offered through doors Point72 does not run.

Morgan Stanley’s shelf added the theme

Counted on EDGAR, HedgePremier has carried 103 feeders since 2009, 15 of them since 2020; it first carried a Point72-named feeder in 2019, and two of this year’s three are Turion’s.

In a Sacra interview on 11 August 2025, an iCapital managing director explained why the shelf exists: “the funds themselves aren’t really set up to take a thousand Morgan Stanley investors or a thousand UBS investors.” By Point72’s Form ADV, Turion’s master asks a $5m minimum and its own feeders $150,000, so the limit a feeder solves is the count: it lets many brokerage clients come in as one investor.

In 2024 the shelf added new Millennium and Jain Global feeders, and in July 2026 Cohen’s theme; the filings do not say whose choice Turion was. By the Turion filing and its Ltd. twin, iCapital’s affiliate sponsors the feeder, Morgan Stanley Smith Barney sells it in all states, and Point72 manages the fund underneath. The plumbing decides who gets in, and it leaves what they own unchanged.

Who gets in is narrow: under Rule 506(b) and section 3(c)(7) of the Investment Company Act, only qualified purchasers, a test of investments held, may buy.

The fees come in layers, as FINRA, the brokers’ regulator, warned of feeder funds in a 20 January 2026 note: “Master-feeder structures typically have several levels of fees.” The Form D names the top one: “Certain private placement clients of Morgan Stanley, Smith Barney, LLC (”MSSB”) are required to pay (i) an upfront placement fee to MSSB and (ii) an annual fee to the fund (which is then paid to MSSB).” Neither HedgePremier filing prints a rate for either fee.

Underneath, Point72’s brochure says it typically charges each fund a monthly advisory fee “at rates ranging from 1.50% (per annum) to 2.85% (per annum) of the net asset value”. Performance compensation, a share of net profits at a rate the brochure does not print, comes on top. If Turion’s rate sits in that range, which a fund’s rate may exceed or undercut, a $10m stake pays $150,000 to $285,000 a year, before the performance fee and Morgan Stanley’s two.

The HedgePremier feeder’s own exit terms are not on file; UBS’s, as a holder of the onshore feeder, are. A&Q Technology Fund, the other UBS holder, owns it with quarterly redemptions on 65 days’ notice. Its report footnotes the holding: “The Investment Fund is subject to an investor level gate of 25%.”

At the end of 2025 that stake was also under a lock-up, with no exit before 31 March 2026 except for a fee. A&Q Long/Short holds the flagship’s US feeder, Point72 Capital, L.P. (the flagship feeder), on 45 days’ notice behind the same gate.

On those terms, a holder who read Turion’s July loss when Hedgeweek reported it, on 6 August, had already missed the 27 July notice date for a 30 September exit, so the earliest way out was 31 December, and then for a quarter of the stake at most. A flagship holder could still give notice for 30 September until 16 August. From January 2027 the flagship lets holders out 8.33% a quarter instead of 25%, Hedgeweek reported, citing Bloomberg.

In a holder’s units, July cost a $10m stake about $1.1m in Turion and about $0.3m in the flagship, before any feeder’s fees. A buyer of Cohen’s theme pays two layers of fees into a fund that lets holders out quarterly. What he holds comes down to each fund’s beta to the Nasdaq-100 on UBS’s books, how far its quarterly return moved per 1% move in the index.

One UBS ledger marks both funds

The same-ledger test needs two kinds of filing and one division. A&Q Long/Short Strategies Fund, a registered UBS fund of hedge funds, files an N-PORT report each quarter with the value of every holding, and its annual report prints each holding’s cost. Value per dollar of cost is the first divided by the second, and its change from one quarter to the next is the holding’s return.

On that ledger the flagship feeder, held since 2018, compounds to +17.6% for 2025, against about 17.5% in the press. For the first half of 2026 it compounds to +14.6%, against about 14.5%.

Turion sits on the same ledger, bought on 1 February 2025 at an unchanged cost of $3.33m, so its six quarters run from February 2025 to June 2026. The one pitfall is a redemption. On A&Q Technology’s books, where a 30 June redemption cut cost by 5.41%, raw value gives +24.1%; per dollar of cost both UBS funds give +31.2%, as A&Q Long/Short’s June filing shows.

Which Point72 does a Morgan Stanley feeder client own on UBS’s books, the hedged platform or a one-theme tech book, and what will the December filing decide?

Below the paid line:

  • The exhibit: both funds on one UBS ledger, quarter by quarter, against the Nasdaq index and the chip index.

  • The Form ADV ownership line, each fund’s return beyond the market, and the betas without the decisive quarter.

  • Our odds on UBS’s December filing, and the dated line that would prove us wrong.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 Navnoor Bawa · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture